Highlights
Profile claimed by owner
About
AI-based Programmable Drug Delivery
Mana.bio specializes in AI-based drug-delivery solutions, with a focus on gene therapy. The companys technology integrates machine learning and nanotechnology for the development of drug-delivery systems.
Mana.bio has created a platform for lipid nanoparticle development for oligonucleotide therapies, including mRNA-based therapeutics, vaccines, and gene therapy.
The technology is powered by an integration of machine learning and nanotechnology in order to identify formulations of lipid nanoparticles drug delivery systems.
Identity
| Name | Mana.bio |
|---|---|
| Slug | mana-bio |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkPTU7qkIDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District,North District |
| HQ city | Haifa |
| HQ address | Haifa, Israel |
Web & social
| Website | https://www.mana.bio/ |
|---|---|
| Careers page | https://www.mana.bio/jobs |
| https://www.linkedin.com/company/76563098 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesLife SciencesBiotechnology
Business models
B2B
Tags
pharmaceuticalsmachine-learningnanotechnologyartificial-intelligencegeneticsdrug-deliverycell-therapytherapeutics
Funding
| Total raised | $24.5M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}